
Anita Turk
Assistant Professor of Clinical Medicine · Indiana University School of Medicine
Credentials: · · · · · · ·
History
- 2015–2018
Hematology and Medical Oncology
- 2012–2015
Internal Medicine
Research
Refining colorectal cancer classification and clinical stratification through a single-cell atlas
Genome biology · 2022 · 194 citations
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023
Journal of the National Comprehensive Cancer Network · 2023 · 191 citations
PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside
Review · Cancer · 2018 · First of 2 authors · 131 citations

5 papers

5 papers

5 papers

5 papers

4 papers
- AS
4 papers

4 papers · 2 as a fellow

3 papers · 3 as a resident
Clinical trials
- 2020–2023
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
Principal investigator · Terminated · Phase 2
Anita Turk
- 2026–2028
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
- 2025–2027
Site PI · Recruiting · Phase 1, Phase 2
Tango Therapeutics, Inc.
- 2025–2027
Site PI · Recruiting · Phase 4
Takeda



